Predicting AMD progression with advanced scans and AI
Part of Eyes & vision clinical trials.
This study is looking at people with intermediate AMD who previously took part in the PINNACLE study. It will use advanced eye scans and machine learning to learn more about how AMD progresses and how to predict it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed the PINNACLE study (a previous AMD study) and had your final visit within the last 12 months.
- You must have intermediate age-related macular degeneration (AMD) in both eyes, or intermediate AMD in one eye and advanced AMD (wet or dry) in the other.
- Your eyes must be clear enough for detailed scans and vision tests.
- You must be able to attend appointments every 4 months for up to 2 years.
- You cannot have other eye diseases that affect your vision, high myopia (more than -6 diopters), or have recently taken medications known to harm the retina.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to track changes in the eyes of people with early or intermediate age-related macular degeneration (AMD). It aims to better understand how the disease progresses and may help doctors personalize care.
This trial uses artificial intelligence to track changes in the eyes of people with advanced age-related macular degeneration (AMD) that has caused a specific type of damage (atrophy) in the retina. The goal is to see if AI can help detect when the disease gets worse, so doctors can personalize monitoring for each patient.
This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.
This study tracks how age-related macular degeneration (AMD) progresses over time and looks at factors that might affect your vision and quality of life. By participating, you'll help researchers understand more about AMD and what might predict better or worse outcomes.
This study is creating a library of eye images to help doctors better diagnose age-related macular degeneration (AMD). You can join if you have healthy eyes or any stage of AMD that has never been treated.
This study tests a web-based eye-tracking tool to monitor vision impairment in people with wet age-related macular degeneration (AMD). You would use your computer at home, which could help reduce the need for frequent clinic visits.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.